← Back to patent-cliff list
CAS 247590-53-0
(4R,7S,10S,13R,16S,19R)-16-Benzyl-10-[4-[(tert-butoxycarbonyl)amino]butyl]-19-[[N-(tert-butoxycarbonyl)-D-phenylalanyl]amino]-7-[(1R)-1-tert-butoxyethyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxylic acid
Codes: (II)120090-7-a
Application context (from source-drug indications)
胃肠道出血Octreotide胃肠胰神经内分泌肿瘤OctreotideHepatocellular carcinomaOctreotideMetastatic cancerOctreotideNeuroendocrine tumourOctreotide
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Octreotide | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
N-(tert-Butoxycarbonyl)-D-phenylalanyl-S-trityl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-(tert-butoxycarbonyl)-L-lysyl-O-tert-butyl-L-threonyl-S-trityl-L-cysteine→(4R,7S,10S,13R,16S,19R)-16-Benzyl-10-[4-[(tert-butoxycarbonyl)amino]butyl]-19-[[N-(tert-butoxycarbonyl)-D-phenylalanyl]amino]-7-[(1R)-1-tert-butoxyethyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxylic acid→(2R,3R)-2-Aminobutane-1,3-diol→(2R,3R)-2-Aminobutane-1,3-diol 1H-benzotriazol-1-ol→N-[(4R,7S,10S,13R,16S,19R)-16-Benzyl-10-[4-[(tert-butoxycarbonyl)amino]butyl]-7-[(1R)-1-tert-butoxyethyl]-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]-Nalpha-(tert-butoxycarbonyl)-D-phenylalaninamide→(V)120090-7-a
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.